N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Second Affiliated Hospital, School of Medicine, Zhejiang University
Capital Medical University
Capital Medical University
OHSU Knight Cancer Institute
Virginia Commonwealth University
Indiana University
Barbara Ann Karmanos Cancer Institute
University of Rochester
NYU Langone Health